Androgens in postmenopausal breast cancer: Excretion, production and interaction with estrogens (Q39958469)

15 September 2017

title

Androgens in postmenopausal breast cancer: Excretion, production and interaction with estrogens (English)

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

20 May 2022

author name string

J. H. Thijssen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A171511

20 May 2022

J. Poortman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A171511

20 May 2022

F. Schwarz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A171511

20 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=171511

20 May 2022

publication date

1 May 1975

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:0022473175900606?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

https://api.elsevier.com/content/article/PII:0022473175900606?httpAccept=text/plain

20 May 2022

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

The Journal of Steroid Biochemistry

20 May 2022

published in

1 reference

15 September 2017

volume

6

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

729-734

1 reference

Epidemiological Characteristics of Breast Cancer in Middle and Late Age

15 September 2017

cites work

1

24

226

Hems

1970

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Etiology of Human Breast Cancer: A Review2

20 May 2022

3

50

21

MacMahon

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Relation between urinary androgen and corticoid excretion and subsequent breast cancer

20 May 2022

4

ii

395

Bulbrook

1971

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Plasma prolactin in breast cancer

20 May 2022

5

9

169

Boyns

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Plasma prolactin and breast cancer.

20 May 2022

8

33

1325

Wilson

1974

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Plasma-prolactin in human breast cancer.

20 May 2022

9

i

433

Kwa

1974

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology

20 May 2022

10

33

1306

Sherman

1974

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

THE RELATION BETWEEN THE URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS AND THE FATE OF PATIENTS AFTER MASTECTOMY

20 May 2022

13

i

945

Bulbrook

1964

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone

20 May 2022

14

i

1154

Bulbrook

1960

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Urinary 17-ketosteroid excretion of women with advanced breast cancer

20 May 2022

Benign and malignant breast disease in South Wales: a study of urinary steroids

15

volume

28

page(s)

667

0 references

17

iv

768

Cameron

1970

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Endocrine profiles and breast cancer

20 May 2022

18

i

165

Argüelles

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast disease

20 May 2022

19

8

131

Brownsey

1972

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Plasma oestradiol and progesterone in benign breast disease

20 May 2022

21

9

553

Swain

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Androstenediol levels in human peripheral plasma

20 May 2022

22

35

818

Rosenfield

1972

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

The production, origin and role of dehydroepiandrosterone and delta 5-androstenediol as androgen prehormones in hirsute women

20 May 2022

23

37

183

Kirschner

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

A gaschromatographic method for the measurement of small amounts of estrogens in urine

20 May 2022

26

11

369

Thijssen

1968

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Plasma Precursors of Estrogen. I. Extent of Conversion of Plasma Δ4-Androstenedione to Estrone in Normal Males and Nonpregnant Normal, Castrate and Adrenalectomized Females

20 May 2022

27

27

1103

Mac Donald

1967

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients

20 May 2022

28

37

101

Poortman

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Standards for the assessment of estrogen receptors in human breast cancer. Report of a workshop on September 29, 1972, at the Antoni van Leeuwenhoek-Huis, Amsterdam

20 May 2022

29

9

379

E.O.R.T.C. Breast Cancer Cooperative Group

publication date

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Interaction of Δ5-Androstene-3β,17β-diol with Estradiol and Dihydrotestosterone Receptors in Human Myometrial and Mammary Cancer Tissue1

20 May 2022

30

40

137

Poortman

1975

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Radioimmunoassay of plasma estrone and estradiol

20 May 2022

32

15

333

Mikhail

1970

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Simultaneous Radioimmunoassay of Plasma FSH, LH, Progesterone, 17-Hydroxyprogesterone, and Estradiol-17β During the Menstrual Cycle

20 May 2022

33

34

312

Abraham

0 references

Simultaneous determination of plasma estrogens, androgens, and progesterone during the human menstrual cycle

34

22

47

Dupon

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Plasma estrogens in postmenopausal women

20 May 2022

35

116

1069

Rader

1973

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Oestrogen fractions during early reproductive life in the aetiology of breast cancer

20 May 2022

36

i

604

Cole

1969

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Oestrogen profiles of Asian and North American women.

20 May 2022

37

ii

900

MacMahon

1971

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Genetic predisposition to carcinoma of the breast: Multiple human genotypes for estrogen 16 alpha hydroxylase activity in caucasians

20 May 2022

39

4

255

Lemon

1972

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Estrogen profiles and breast cancer

20 May 2022

40

ii

1378

Lipsett

1971

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

Hormones and human breast cancer

20 May 2022

11

1 reference

https://api.crossref.org/works/10.1016/0022-4731(75)90060-6

21 December 2022

Identifiers

1 reference

15 September 2017

1 reference